1. National Institute of Health

    0 Comments Leave a Comment

    1-9 of 9

    1. Mentioned In 9 Articles

    2. Fingolimod treatment in multiple sclerosis leads to increased macular volume

      Explore Neurology (Jan 7 2013) Journal Articles

      ...ing Studies: 1. NONE Research Support, Commercial Entities: 1. NONE Research Support, Government Entities: 1. NIH CTSA KL2 RR024130 Research Support, Academic Entities: 1. NONE Research Support, Foundations and Societies... (Read Full Article)

      Mentions:   National Institute of Health

    3. Sex-specific differences in retinal nerve fiber layer thinning after acute optic neuritis

      Explore Neurology (Oct 29 2012) Journal Articles

      ...), “Studying Models and Mechanisms of Diseases of the Optic Nerve.” Role: Co- investigator (1.8 months/year); NIH (NEI) R01EY017066-01, “Low-cost, portable, computer assisted imaging for diabetic retinopathy” (Co- invest... (Read Full Article)

      Mentions:   National Institute of Health

    4. The Role of Spectral-Domain OCT in the Diagnosis and Management of Neovascular Age-Related Macular Degeneration

      Explore SLACK Journals (Aug 13 2011) AMD

      ...llenge grant to the New England Eye Center/Department of Ophthalmology–Tufts University School of Medicine, NIH contracts RO1-EY11289-23, R01-EY13178-07, R01-EY013516-07, Air Force Office of Scientific Research FA9550-... (Read Full Article)

      Mentions:   Carl Zeiss Meditec   Duker, Jay S. MD   New England Eye Center

    5. High-Resolution In Vivo Imaging in Achromatopsia

      Explore Ophthalmology (Jan 5 2011) Journal Articles , Retina

      To characterize the retinal changes in patients with achromatopsia using an ultrahigh-resolution (UHR) spectral-domain optical coherence tomography (OCT) to examine how human achromatopsia corresponds to its animal model. (Read Full Article)

      Mentions:   National Institute of Health

    6. Retinal Layer Thickness Changes in Eyes With Preserved VisualAcuity and Diffuse Diabetic Macular Edema on Optical CoherenceTomography

      Explore Ophthalmic Surgery, Lasers and Imaging (Nov 29 2010) Journal Articles , Diabetic Retinopathy , Retina

      ...search, October 4-7, 2007, Portoroz, Slovenia. Supported by a Juvenile Diabetes Research Foundation grant, an NIH center grant P30-EY014801, an unrestricted grant to the University of Miami from Research to Prevent Blind... (Read Full Article)

      Mentions:   Bascom Palmer Eye Institute   National Institute of Health

    7. Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices

      Explore Nature Publishing Group (Jul 20 2009) Journal Articles , AMD

      ... Building 6, Room 215, Bethesda, MD 20892, USA. Tel: +1 301 905 7301; Fax: +1 301 496 1759. E-mail: wongw@nei.nih.gov To determine whether optical coherence tomography (OCT) device-type influences clinical grading of OCT... (Read Full Article)

      Mentions:   Cirrus HD-OCT   Stratus OCT   National Institute of Health

    8. Researchers publish super-resolution OCT retina scans to encourage development of AMD-diagnosis software

      Explore BioOptics World (Apr 5 2009) News , AMD

      Researchers publish super-resolution OCT retina scans to encourage development of AMD-diagnosis software MARCH 20, 2009--An optical coherence tomography (OCT) system with twice the resolution of commercial OCT instruments is the cornerstone of an unprecedented project designed to shed new light on the development of age-related macular degeneration (AMD)--the leading cause of vision loss in Americans and Europeans over 50. The project ... (Read Full Article)

      Mentions:   Duker, Jay S. MD   Schuman, Joel MD   New England Eye Center

    9. Composite Spectral Domain Optical Coherence Tomography Images of Diabetic Tractional Retinal Detachment

      Explore Ophthalmic Surgery, Lasers and Imaging (Aug 19 2008) Journal Articles , Retina

      ...epted for publication March 19, 2008. Supported in part by a research grant from Carl Zeiss Meditec, Inc., by National Institute of Health Center Grant P30 EY014801, and by an unrestricted grant from Research to Prevent ... (Read Full Article)

      Mentions:   Carl Zeiss Meditec   Bascom Palmer Eye Institute   National Institute of Health

    10. Who will pay for the trial’s drugs? NEI Awaits CMS Policy Decision on AMD Clinical Trial

      Explore Optometric Management (Apr 15 2007) News

      ...S’ role According to an article appearing in the Feb. 22 issue of The Wall Street Journal, Genentech said the NIH should be “studying cutting-edge science, not comparing two approved drugs.” The company has declined to s... (Read Full Article)

      Mentions:   National Institute of Health   Genentech   Gerson, Jeffry D. OD

    11. 1-9 of 9